Grapefruit juice-drug interactions. 1998.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2004-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1365-2125.2004.02305.XPMID 15595979PMCID PMC1884681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics on felodipine — and its potential clinical relevance

  2004cited by this paper
• Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects

  2004cited by this paper
• Grapefruit juice-drug interactions.

  1998cited by this paper
• Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

  1997cited by this paper
• Combined use of astemizole and ketoconazole resulting in torsade de pointes.

  1997cited by this paper
• The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice

  1997cited by this paper
• Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men

  1997cited by this paper
• Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction.

  1997cited by this paper
• Drug interactions with grapefruit: Whose responsibility is it to warn the public?

  1997cited by this paper
• Grapefruit juice—terfenadine single‐dose interaction: Magnitude, mechanism, and relevance

  1997cited by this paper
• Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.

  1997cited by this paper
• First‐pass metabolism of midazolam by the human intestine

  1996cited by this paper
• Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

  1996cited by this paper
• Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram

  1996cited by this paper
• Erythromycin‐felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice

  1996cited by this paper
• Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients.

  1996cited by this paper
• Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic?

  1996cited by this paper
• Cisapride and fatal arrhythmia.

  1996cited by this paper
• Can grapefruit juice influence ethinylestradiol bioavailability?

  1996cited by this paper
• Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers

  1996cited by this paper
• Effect of Grapefruit Juice on the Pharmacokinetics and Pharmacodynamics of Quinidine in Healthy Volunteers

  1996cited by this paper
• Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.

  1996cited by this paper
• Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism

  1996cited by this paper
• Grapefruit Juice Alters the Systemic Bioavailability and Cardiac Repolarization of Terfenadine in Poor Metabolizers of Terfenadine

  1996cited by this paper
• Cisapride

  1996cited by this paper
• Pravastatin-induced rhabdomyolysis in a patient with mixed connective tissue disease.

  1996cited by this paper
• [Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity].

  1995cited by this paper
• The fate of naringin in humans: A key to grapefruit juice‐drug interactions?

  1995cited by this paper
• Intraoperative rhabdomyolysis in a patient receiving pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor.

  1995cited by this paper
• Factors affecting the absolute bioavailability of nifedipine.

  1995cited by this paper
• Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers

  1995cited by this paper
• Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice

  1995cited by this paper
• Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole.

  1995cited by this paper
• Disposition of intravenous and oral cyclosporine after administration with grapefruit juice

  1995cited by this paper
• Effect of grapefruit juice on blood cyclosporin concentration.

  1995cited by this paper
• Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?

  1995cited by this paper
• Effect of grapefruit juice on blood cyclosporin concentration.

  1995cited by this paper
• Torsades de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma.

  1995cited by this paper
• Interaction between grapefruit juice and midazolam in humans

  1995cited by this paper
• The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients

  1995cited by this paper
• Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

  1995cited by this paper
• Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function.

  1995cited by this paper
• Nifedipine in ischemic heart disease.

  1995cited by this paper
• Lacking effect of grapefruit juice on theophylline pharmacokinetics.

  1995cited by this paper
• Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.

  1995cited by this paper
• Grapefruit Juice and Drugs

  1994cited by this paper
• Torsade de pointes induced by terfenadine in a patient with long QT syndrome.

  1994cited by this paper
• Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity.

  1994cited by this paper
• Torsades de pointes induced by erythromycin and terfenadine.

  1994cited by this paper
• Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation.

  1994cited by this paper
• Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.

  1994cited by this paper
• Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine.

  1994cited by this paper
• Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects.

  1994cited by this paper
• Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women.

  1994cited by this paper
• Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A.

  1993cited by this paper
• Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.

  1993cited by this paper
• Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin

  1993cited by this paper
• Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine.

  1993cited by this paper
• Itraconazole Affects Single‐Dose Terfenadine Pharmacokinetics and Cardiac Repolarization Pharmacodynamics

  1993cited by this paper
• Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics

  1993cited by this paper
• Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.

  1993cited by this paper
• Trough concentrations of cyclosporine in blood following administration with grapefruit juice.

  1993cited by this paper
• Torsades de pointes after terfenadine-itraconazole interaction.

  1993cited by this paper
• Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.

  1993cited by this paper
• Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice.

  1993cited by this paper
• Mechanism of the cardiotoxic actions of terfenadine.

  1993cited by this paper
• Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart.

  1993cited by this paper
• Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.

  1992cited by this paper
• Torsades de Pointes after treatment with terfenadine and ketoconazole.

  1992cited by this paper
• Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

  1992cited by this paper
• Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans

  1991cited by this paper
• Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes.

  1991cited by this paper
• A population study of the pharmacokinetics of felodipine.

  1991cited by this paper
• Rhabdomyolysis associated with lovastatin and erythromycin use.

  1991cited by this paper
• Rhabdomyolysis and simvastatin.

  1991cited by this paper
• First-pass metabolism of cyclosporin by the gut.

  1991cited by this paper
• Interaction of citrus juices with felodipine and nifedipine.

  1991cited by this paper
• Plasma Concentration—Effect Relationships of Intravenous and Extended‐Release Oral Felodipine in Hypertensive Patients

  1990cited by this paper
• Torsades de pointes occurring in association with terfenadine use.

  1990cited by this paper
• In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids.

  1990cited by this paper
• Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.

  1990cited by this paper
• Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

  1989cited by this paper
• Cardiotoxic effect with convulsions in terfenadine overdose.

  1989cited by this paper
• Ethanol enhances the hemodynamic effects of felodipine.

  1989cited by this paper
• Electrophysiologic Effects of Dextro‐ and Levo‐Verapamil on Sinus Node and AV Node Function in Humans

  1988cited by this paper
• Pharmacokinetics of Calcium Antagonists Under Development

  1988cited by this paper
• Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin.

  1988cited by this paper
• Felodipine kinetics in healthy men

  1985cited by this paper
• Vasodilator and hypotensive effects of the optical isomers of nicardipine (YC-93), a new Ca2+-antagonist.

  1982cited by this paper
• Pharmacokinetics and biotransformation studies of terfenadine in man.

  1982cited by this paper
• Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids.

  1981cited by this paper

• Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans.

  2025cites this paper
• Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs

  2025cites this paper
• Enhancing drug-food interaction prediction with precision representations through multilevel self-supervised learning

  2024cites this paper
• Orientin Enhances Colistin-Mediated Bacterial Lethality through Oxidative Stress Involvement

  2022influential citation
• Phytochemical characterisation of two news blood grapefruits by means of HPLC-MS

  2022cites this paper
• beta-caryophyllene oxide and trans-nerolidol affect enzyme activity of CYP3A4 - in vitro and in silico studies.

  2019cites this paper
• Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response

  2019cites this paper
• Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4β-Hydroxycholesterol—an Interaction Study in Healthy Volunteers

  2019cites this paper
• Common interactions between drugs and herbal supplements used in alternative medicine

  2018cites this paper
• Storage stability study of porcine hepatic and intestinal cytochrome P450 isoenzymes by use of a newly developed and fully validated highly sensitive HPLC-MS/MS method

  2018cites this paper
• What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects

  2018cites this paper
• Nutrition Recommendations While Taking Warfarin

  2018cites this paper
• Grapefruit-Like Varieties with Low Furanocoumarin Content

  2017cites this paper
• Pharmacokinetic drug‐drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy

  2017cites this paper
• Evaluation of real‐life dosing of oral medicines with respect to fluid and food intake in a Dutch‐speaking population

  2017cites this paper
• Overcoming Challenges With Statin Therapy

  2016cites this paper
• Breeding and Analysis of Two New Grapefruit-Like Varieties with Low Furanocoumarin Content

  2016cites this paper
• Gesundheitsschädigende Wirkungen von Koffein

  2016cites this paper
• In vitro metabolism of bencycloquidium bromide and its inhibitory effects on human P450 isoenzymes: implication of CYP2D6, CYP2C19 and CYP3A4/5

  2016cites this paper
• Adverse Cardiovascular Effects and Drug Interactions with Herbs

  2016cites this paper
• A Comprehensive Review of Potential Warfarin-Fruit Interactions

  2015cites this paper
• Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.

  2015cites this paper
• Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: a new mechanism of beverage-drug interaction.

  2015cites this paper
• Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor.

  2015cites this paper
• Pre‐systemic Elimination of Tilidine: Localization and Consequences for the Formation of the Active Metabolite Nortilidine

  2015cites this paper
• Plants with potential use on obesity and its complications

  2015cites this paper
• Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy.

  2015cites this paper
• Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)

  2014cites this paper
• The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism

  2014cites this paper
• Identification of genes associated with low furanocoumarin content in grapefruit.

  2014cites this paper
• An Updated Mini Review on Grapefruit: Interactions with Drugs, Obesity and Cardiovascular Risk Factors

  2014cites this paper
• Flavonoids and polymer derivatives as CYP3A4 inhibitors for improved oral drug bioavailability.

  2013cites this paper
• Effect of blueberry juice on clearance of buspirone and flurbiprofen in human volunteers.

  2013cites this paper
• Comparison of inhibitory duration of grapefruit juice on organic anion-transporting polypeptide and cytochrome P450 3A4.

  2013cites this paper
• Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats

  2012cites this paper
• Editors' pick 2011

  2012cites this paper
• Potent inhibition of CYP1A2 by Frutinone A, an active ingredient of the broad spectrum antimicrobial herbal extract from P. fruticosa

  2012cites this paper
• Pharmacogenomics in clinical therapeutics

  2012cites this paper
• Isothiocyanate–drug interactions in the human adenocarcinoma cell line Caco-2

  2012cites this paper
• Understanding Aromatase: A Mechanistic Basis for Drug Interactions and New Inhibitors

  2012cites this paper
• Pharmacogenomics Principles: Introduction to Personalized Medicine

  2012cites this paper
• Herb-drug interactions: methods to identify potential influence of genetic variations in genes encoding drug metabolizing enzymes and drug transporters.

  2012cites this paper
• NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements

  2012cites this paper
• Interactions between drugs and sulforaphane modulate the drug metabolism enzymatic system

  2012cites this paper
• Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects

  2011cites this paper
• Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.

  2011cites this paper
• Cisapride: What can we learn from the rise and fall of a prokinetic?

  2011cites this paper
• Daily Honey Consumption Does Not Change CYP3A Activity in Humans

  2011cites this paper
• Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily.

  2011cites this paper
• Biological effects of Byrsocarpus coccineus in vitro

  2011cites this paper
• Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and/or P-glycoprotein.

  2011cites this paper
• Drug Interactions and Adventures in Polypharmacy

  2011cites this paper
• Diverse approaches for the enhancement of oral drug bioavailability

  2011cites this paper
• Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

  2010cites this paper
• Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients

  2010cites this paper
• Effect of pomegranate juice pre-treatment on the transport of carbamazepine across rat intestine

  2010cites this paper
• Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy

  2010cites this paper
• The influence of Nifadin®, Niprisan® and Niprd/92/001/1-1 (AM-1) on the pharmacokinetics of metronidazole in rats

  2010cites this paper
• Effect of danshen extract on the activity of CYP3A4 in healthy volunteers.

  2010cites this paper
• Grapefruit and Other Fruit Juices Interactions with Medicines

  2009cites this paper
• Medication and food issues for overactive bladder/lower urinary tract symptoms: When do we eat?

  2009cites this paper
• ORAL PREMEDICATION FOR PEDIATRIC CARDIAC SURGERY: A COMPARISON OF MIDAZOLAM, KETAMINE AND MIDAZOLAM PLUS KETAMINE

  2008cites this paper
• Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies.

  2008cites this paper
• Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.

  2008cites this paper
• Effect of tangerine juice on cyclosporine levels in renal transplant children

  2008cites this paper
• Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies

  2008cites this paper
• Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100

  2008cites this paper
• Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions.

  2007cites this paper
• Medicinal importance of grapefruit juice and its interaction with various drugs

  2007cites this paper
• Clinical relevance of the small intestine as an organ of drug elimination: drug–fruit juice interactions

  2007cites this paper
• Effect of grapefruit juice on the disposition of manidipine enantiomers in healthy subjects.

  2006cites this paper
• Stereoselective interaction of manidipine and grapefruit juice: a new twist on an old tale.

  2006cites this paper
• Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects?

  2006cites this paper
• Warfarin-g›da etkileflmesi: Olgu sunumu ve literatürün gözden geçirilmesi Warfarin-food interaction: a case report and review of the literature

  2006cites this paper
• Rhabdomyolysis associated with pomegranate juice consumption.

  2006cites this paper
• DEVELOPMENT OF NOVEL FURANOCOUMARIN DIMERS AS POTENT AND SELECTIVE INHIBITORS OF CYP3A4

  2006cites this paper
• Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.

  2006cites this paper
• Effects of grapefruit juice on the absorption of levothyroxine.

  2005cites this paper
• 6′7′‐Dihydroxybergamottin Contributes to the Grapefruit Juice Effect

  2004cites this paper
• Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid.

  2004cites this paper
• Potential of chemotherapy–herb interactions in adult cancer patients

  2004cites this paper
• Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy.

  2004cites this paper
• Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese.

  2004cites this paper
• Food–drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance

  2004cites this paper
• The effect of itraconazole on the pharmacokinetics and pharmacodynamics of bromazepam in healthy volunteers

  2003cites this paper
• Understanding and preventing drug interactions in elderly patients.

  2003cites this paper